The Prothrombotic Activity of Cancer Cells in the Circulation

Overview

Journal Blood Rev

Publisher Elsevier

Specialty Hematology

Date 2015 Jul 30

PMID 26219246

Citations 44

Authors

Annachiara Mitrugno

Garth W Tormoen

Peter Kuhn

Owen J T McCarty

Affiliations

Soon will be listed here.

Abstract

The hemostatic system is often subverted in patients with cancer, resulting in life-threatening venous thrombotic events. Despite the multifactorial and complex etiology of cancer-associated thrombosis, changes in the expression and activity of cancer-derived tissue factor (TF) - the principle initiator of the coagulation cascade - are considered key to malignant hypercoagulopathy and to the pathophysiology of thrombosis. However, many of the molecular and cellular mechanisms coupling the hemostatic degeneration to malignancy remain largely uncharacterized. In this review we discuss some of the tumor-intrinsic and tumor-extrinsic mechanisms that may contribute to the prothrombotic state of cancer, and we bring into focus the potential for circulating tumor cells (CTCs) in advancing our understanding of the field. We also summarize the current status of anti-coagulant therapy for the treatment of thrombosis in patients with cancer.

Citing Articles

Association between tumor markers elevation and poor functional outcomes after acute ischemic stroke: a longitudinal stroke center-based study.

Gu Y, Li Y, Gao L Ann Med. 2024; 56(1):2426753.

PMID: 39575674 PMC: 11587720. DOI: 10.1080/07853890.2024.2426753.

Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells.

Tang M, Zhang Z, Wang P, Zhao F, Miao L, Wang Y Acta Pharm Sin B. 2024; 14(8):3457-3475.

PMID: 39220884 PMC: 11365446. DOI: 10.1016/j.apsb.2024.04.034.

What to Do When There Is Something Unexpected?.

Ivan V, Lighezan D, Ardelean M, Baltes N, Faur A, Ciubotaru P Life (Basel). 2024; 14(2).

PMID: 38398722 PMC: 10890187. DOI: 10.3390/life14020213.

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.

Shafqat A, Omer M, Ahmed E, Mushtaq A, Ijaz E, Ahmed Z Front Immunol. 2023; 14:1200941.

PMID: 37520562 PMC: 10374407. DOI: 10.3389/fimmu.2023.1200941.

The role of coagulome in the tumor immune microenvironment.

Wahab R, Hasan M, Azam Z, Grippo P, Al-Hilal T Adv Drug Deliv Rev. 2023; 200:115027.

PMID: 37517779 PMC: 11099942. DOI: 10.1016/j.addr.2023.115027.

References

Klement G, Yip T, Cassiola F, Kikuchi L, Cervi D, Podust V . Platelets actively sequester angiogenesis regulators. Blood. 2008; 113(12):2835-42. PMC: 2661866. DOI: 10.1182/blood-2008-06-159541. View

Ahamed J, Versteeg H, Kerver M, Chen V, Mueller B, Hogg P . Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A. 2006; 103(38):13932-7. PMC: 1599891. DOI: 10.1073/pnas.0606411103. View

Ruf W, Mueller B . Tissue factor signaling. Thromb Haemost. 1999; 82(2):175-82. View

Milsom C, Anderson G, Weitz J, Rak J . Elevated tissue factor procoagulant activity in CD133-positive cancer cells. J Thromb Haemost. 2007; 5(12):2550-2. DOI: 10.1111/j.1538-7836.2007.02766.x. View

Perry J, Julian J, Laperriere N, Geerts W, Agnelli G, Rogers L . PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost. 2010; 8(9):1959-65. DOI: 10.1111/j.1538-7836.2010.03973.x. View

Milsom C, Yu J, May L, Meehan B, Magnus N, Al-Nedawi K . The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. Thromb Res. 2007; 120 Suppl 2:S82-91. DOI: 10.1016/S0049-3848(07)70135-4. View

Camerer E, Qazi A, Duong D, Cornelissen I, Advincula R, Coughlin S . Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood. 2004; 104(2):397-401. DOI: 10.1182/blood-2004-02-0434. View

Kuznetsov H, Marsh T, Markens B, Castano Z, Greene-Colozzi A, Hay S . Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov. 2012; 2(12):1150-65. PMC: 3517696. DOI: 10.1158/2159-8290.CD-12-0216. View

Chaffer C, Weinberg R . A perspective on cancer cell metastasis. Science. 2011; 331(6024):1559-64. DOI: 10.1126/science.1203543. View

10.

King M, Phillips K, Mitrugno A, Lee T, de Guillebon A, Chandrasekaran S . A physical sciences network characterization of circulating tumor cell aggregate transport. Am J Physiol Cell Physiol. 2015; 308(10):C792-802. PMC: 4436994. DOI: 10.1152/ajpcell.00346.2014. View

11.

Ho-Tin-Noe B, Goerge T, Cifuni S, Duerschmied D, Wagner D . Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res. 2008; 68(16):6851-8. PMC: 2547489. DOI: 10.1158/0008-5472.CAN-08-0718. View

12.

Schwarzenbach H, Hoon D, Pantel K . Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011; 11(6):426-37. DOI: 10.1038/nrc3066. View

13.

Boccaccio C, Sabatino G, Medico E, Girolami F, Follenzi A, Reato G . The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature. 2005; 434(7031):396-400. DOI: 10.1038/nature03357. View

14.

Pinedo H, Verheul H, DAmato R, Folkman J . Involvement of platelets in tumour angiogenesis?. Lancet. 1998; 352(9142):1775-7. DOI: 10.1016/s0140-6736(98)05095-8. View

15.

Li R, Ren M, Chen N, Luo M, Deng X, Xia J . Presence of intratumoral platelets is associated with tumor vessel structure and metastasis. BMC Cancer. 2014; 14:167. PMC: 4016490. DOI: 10.1186/1471-2407-14-167. View

16.

Tormoen G, Cianchetti F, Bock P, McCarty O . Development of coagulation factor probes for the identification of procoagulant circulating tumor cells. Front Oncol. 2012; 2:110. PMC: 3434442. DOI: 10.3389/fonc.2012.00110. View

17.

Phillips K, Lee A, Tormoen G, Rigg R, Kolatkar A, Luttgen M . The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation. Am J Physiol Cell Physiol. 2014; 308(3):C229-36. PMC: 4312838. DOI: 10.1152/ajpcell.00315.2014. View

18.

Mackman N . The role of tissue factor and factor VIIa in hemostasis. Anesth Analg. 2009; 108(5):1447-52. PMC: 2838713. DOI: 10.1213/ane.0b013e31819bceb1. View

19.

Burdick M, Konstantopoulos K . Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow. Am J Physiol Cell Physiol. 2004; 287(2):C539-47. DOI: 10.1152/ajpcell.00450.2003. View

20.

Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y . Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation. 2002; 106(15):2019-25. DOI: 10.1161/01.cir.0000031332.45480.79. View